Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Protein digestion and absorption,7.936443356203379e-05,5.746608315098468,54.256373864912725,"['COL27A1', 'COL5A1', 'COL11A1', 'COL12A1', 'COL23A1', 'COL21A1', 'PRCP', 'COL9A2', 'SLC38A2']",0.019126828488450143,0,0,9
2,Platelet activation,0.02185541718433914,2.6639651416122003,10.185155140768135,"['VASP', 'RAP1A', 'PPP1R12A', 'TBXAS1', 'TLN1', 'ADCY8', 'RASGRP1']",0.9985108186980352,0,0,7
3,Glycerophospholipid metabolism,0.03614122630917864,2.590909090909091,8.602650024812636,"['MBOAT2', 'PNPLA6', 'GPCPD1', 'LPIN2', 'PLPP1', 'AGPAT3']",0.9985108186980352,0,0,6
4,Protein export,0.0422464465956785,4.262203023758099,13.486612125364315,"['SRP72', 'SEC62', 'SEC11A']",0.9985108186980352,0,0,3
5,Antigen processing and presentation,0.046663405764745126,3.16017316017316,9.685282976125885,"['PSME2', 'HSPA2', 'CALR', 'HLA-E']",0.9985108186980352,0,0,4
6,Arachidonic acid metabolism,0.04709624924080371,4.058932428262882,12.40231934369919,"['CBR1', 'TBXAS1', 'PTGDS']",0.9985108186980352,0,0,3
7,cGMP-PKG signaling pathway,0.04710270941269176,2.0939866191258365,6.398018552566423,"['VASP', 'PPP3CB', 'PPP1R12A', 'IRS1', 'ADORA1', 'KCNMB3', 'ADCY8', 'CREB5']",0.9985108186980352,0,0,8
8,Glycerolipid metabolism,0.050368883101597886,3.0745290745290745,9.187866402000362,"['MBOAT2', 'LPIN2', 'PLPP1', 'AGPAT3']",0.9985108186980352,0,0,4
9,Purine metabolism,0.06262454084249529,2.0778867102396514,5.756988870545333,"['ENTPD5', 'ENPP4', 'AK4', 'AMPD2', 'NUDT16', 'ADCY8', 'AK9']",0.9985108186980352,0,0,7
10,Selenocompound metabolism,0.07083035567707913,5.158699059561129,13.657488709489856,"['TXNRD1', 'MTR']",0.9985108186980352,0,0,2
11,Lysosome,0.07653965730696813,1.974266054056386,5.073757694049687,"['SCARB2', 'AP1B1', 'SLC17A5', 'TPP1', 'AP3B1', 'ARSG', 'AP3B2']",0.9985108186980352,0,0,7
12,"Glycine, serine and threonine metabolism",0.08146693123872102,3.1555075593952484,7.912618517285694,"['GLDC', 'CHDH', 'SDSL']",0.9985108186980352,0,0,3
13,mTOR signaling pathway,0.08274166218444363,1.838568812508804,4.58177236811204,"['RPS6KA3', 'FZD3', 'IRS1', 'CAB39L', 'RRAGD', 'FZD9', 'FNIP1', 'LPIN2']",0.9985108186980352,0,0,8
14,Glutathione metabolism,0.13147548533062503,2.504510227417101,5.081488127880956,"['ODC1', 'GSR', 'PRDX6']",0.9985108186980352,0,0,3
15,Long-term potentiation,0.14210535926140302,2.065486029122393,4.030148517663324,"['RPS6KA3', 'PPP3CB', 'RAP1A', 'ADCY8']",0.9985108186980352,0,0,4
16,Glucagon signaling pathway,0.14329581240902362,1.8695056513300605,3.632158150088106,"['PYGB', 'PPP3CB', 'SIK2', 'PFKP', 'CREB5']",0.9985108186980352,0,0,5
17,Thyroid hormone signaling pathway,0.1452091141734405,1.7406388642413486,3.358702651186985,"['NOTCH2', 'NCOA1', 'MED13', 'PLCE1', 'PFKP', 'PLCD1']",0.9985108186980352,0,0,6
18,Proteoglycans in cancer,0.14565254073488523,1.591962622530308,3.0669659029071052,"['FZD3', 'MRAS', 'PPP1R12A', 'FZD9', 'HSPB2', 'PLCE1', 'IQGAP1', 'HSPG2']",0.9985108186980352,0,0,8
19,Regulation of lipolysis in adipocytes,0.14735852400209606,2.365010799136069,4.528727778538895,"['IRS1', 'ADORA1', 'ADCY8']",0.9985108186980352,0,0,3
20,Rap1 signaling pathway,0.15336543594032773,1.5697635898208102,2.9431995713991435,"['VASP', 'ENAH', 'PDGFRB', 'MRAS', 'RAP1A', 'PLCE1', 'TLN1', 'ADCY8']",0.9985108186980352,0,0,8
21,Mismatch repair,0.1599844049611887,2.9848003629764066,5.470180757843223,"['MSH2', 'MLH3']",0.9985108186980352,0,0,2
22,Cysteine and methionine metabolism,0.16382463957766566,2.2401955212004094,4.052421164567797,"['AHCY', 'MTR', 'SDSL']",0.9985108186980352,0,0,3
23,Insulin secretion,0.16800910754558954,1.9248660943576197,3.433455044763909,"['ABCC8', 'KCNMB3', 'ADCY8', 'CREB5']",0.9985108186980352,0,0,4
24,Longevity regulating pathway,0.17072605000983898,1.7534345625451917,3.099537603468927,"['IRS1', 'SESN1', 'HSPA2', 'ADCY8', 'CREB5']",0.9985108186980352,0,0,5
25,Butanoate metabolism,0.17221659763921465,2.8353448275862068,4.987378089483372,"['OXCT1', 'L2HGDH']",0.9985108186980352,0,0,2
26,Regulation of actin cytoskeleton,0.17347550263072176,1.5168558951965065,2.657105117099804,"['CYFIP2', 'ENAH', 'PDGFRB', 'MRAS', 'PPP1R12A', 'SPATA13', 'IQGAP1', 'ARHGEF6']",0.9985108186980352,0,0,8
27,Pyrimidine metabolism,0.18080535312514964,2.127861771058315,3.639354809853,"['ENTPD5', 'UPP2', 'AK9']",0.9985108186980352,0,0,3
28,Estrogen signaling pathway,0.18808970903399705,1.69042454291912,2.8244226113858946,"['NCOA1', 'GPER1', 'HSPA2', 'ADCY8', 'CREB5']",0.9985108186980352,0,0,5
29,Glutamatergic synapse,0.20605654136159515,1.6317600418879497,2.5775357910101997,"['GRK3', 'PPP3CB', 'DLGAP1', 'ADCY8', 'SLC38A2']",0.9985108186980352,0,0,5
30,Basal cell carcinoma,0.2070943501641145,1.9789542418001909,3.11602333672612,"['FZD3', 'FZD9', 'GLI1']",0.9985108186980352,0,0,3
31,Hippo signaling pathway,0.22179859123484294,1.5078491727587533,2.2707990741937474,"['FZD3', 'DCHS2', 'PPP2R2B', 'FZD9', 'CTNNA1', 'TEAD1']",0.9985108186980352,0,0,6
32,Glyoxylate and dicarboxylate metabolism,0.2223701685485409,2.3620689655172415,3.551162496487196,"['GLDC', 'ACO1']",0.9985108186980352,0,0,2
33,Thyroid hormone synthesis,0.23416992048533689,1.8494694337496478,2.6848900743574293,"['GSR', 'ADCY8', 'CREB5']",0.9985108186980352,0,0,3
34,cAMP signaling pathway,0.23760051000586294,1.4200435729847494,2.040836275458215,"['RAP1A', 'PPP1R12A', 'ADORA1', 'PLCE1', 'GLI1', 'ADCY8', 'CREB5']",0.9985108186980352,0,0,7
35,Renin-angiotensin system,0.2427957429113812,4.045775729646698,5.726936149228618,['PRCP'],0.9985108186980352,0,0,1
36,Synthesis and degradation of ketone bodies,0.2427957429113812,4.045775729646698,5.726936149228618,['OXCT1'],0.9985108186980352,0,0,1
37,Notch signaling pathway,0.2433334367872026,1.8099811589540922,2.558087292646427,"['NOTCH2', 'TLE2', 'DTX4']",0.9985108186980352,0,0,3
38,Circadian rhythm,0.247878219708436,2.1800397877984086,3.040758089231211,"['CRY2', 'RORA']",0.9985108186980352,0,0,2
39,Cell adhesion molecules,0.2613138746137752,1.5757575757575757,2.114718681570404,"['IGSF11', 'VCAN', 'NECTIN3', 'HLA-E']",0.9985108186980352,0,0,4
40,AMPK signaling pathway,0.26292203422060034,1.477765726681128,1.9741438924304575,"['IRS1', 'CAB39L', 'PPP2R2B', 'PFKP', 'CREB5']",0.9985108186980352,0,0,5
41,Focal adhesion,0.26354005903480726,1.3705506723762302,1.8276977064154973,"['VASP', 'PDGFRB', 'RAP1A', 'PPP1R12A', 'CAPN2', 'COL9A2', 'TLN1']",0.9985108186980352,0,0,7
42,Phototransduction,0.26867638537764155,3.539784946236559,4.652154053948691,['GUCA1B'],0.9985108186980352,0,0,1
43,Thiamine metabolism,0.26867638537764155,3.539784946236559,4.652154053948691,['AK4'],0.9985108186980352,0,0,1
44,Gastric acid secretion,0.27113513502782594,1.7009935205183586,2.220031160865941,"['KCNJ10', 'KCNJ16', 'ADCY8']",0.9985108186980352,0,0,3
45,Nitrogen metabolism,0.29367428044223115,3.1462365591397847,3.8550333647671122,['CA12'],0.9985108186980352,0,0,1
46,DNA replication,0.29903061502380646,1.888793103448276,2.2801686369939893,"['RNASEH2C', 'MCM5']",0.9985108186980352,0,0,2
47,ECM-receptor interaction,0.2992570835093664,1.6043441053017646,1.9355645779947546,"['COL9A2', 'NPNT', 'HSPG2']",0.9985108186980352,0,0,3
48,Cushing syndrome,0.3026381179890746,1.390200331759602,1.6615917891064447,"['FZD3', 'RAP1A', 'FZD9', 'ADCY8', 'CREB5']",0.9985108186980352,0,0,5
49,Human T-cell leukemia virus 1 infection,0.30652596030317436,1.2980904780212739,1.534930756733465,"['PPP3CB', 'CDC27', 'CALR', 'TLN1', 'ADCY8', 'HLA-E', 'CREB5']",0.9985108186980352,0,0,7
50,Choline metabolism in cancer,0.307336669430772,1.453879453879454,1.7153036835577262,"['PDGFRB', 'SLC44A2', 'GPCPD1', 'PLPP1']",0.9985108186980352,0,0,4
51,Allograft rejection,0.3178194744630588,2.8313978494623657,3.245551361526629,['HLA-E'],0.9985108186980352,0,0,1
52,Graft-versus-host disease,0.3178194744630588,2.8313978494623657,3.245551361526629,['HLA-E'],0.9985108186980352,0,0,1
53,Phospholipase D signaling pathway,0.32284058329032417,1.3501704369383327,1.5264981429310218,"['PDGFRB', 'MRAS', 'ADCY8', 'PLPP1', 'AGPAT3']",0.9985108186980352,0,0,5
54,Type II diabetes mellitus,0.32443844516198117,1.7704741379310345,1.9929509481776746,"['IRS1', 'ABCC8']",0.9985108186980352,0,0,2
55,Synaptic vesicle cycle,0.32752362679019775,1.5180499845726627,1.694439929497005,"['RIMS1', 'SLC6A9', 'AP2A1']",0.9985108186980352,0,0,3
56,Autoimmune thyroid disease,0.3411409932925384,2.573802541544477,2.768020181028312,['HLA-E'],0.9985108186980352,0,0,1
57,Adherens junction,0.3463686711139218,1.465480002979072,1.5537774413419903,"['CTNNA1', 'IQGAP1', 'NECTIN3']",0.9985108186980352,0,0,3
58,MAPK signaling pathway,0.34796060437030674,1.198539156162357,1.2652570505506207,"['PDGFRB', 'RPS6KA3', 'PPP3CB', 'MRAS', 'RAP1A', 'MAPT', 'HSPA2', 'RASGRP1', 'DUSP16']",0.9985108186980352,0,0,9
59,Shigellosis,0.3496203604039105,1.2132732410153422,1.2750378244811709,"['RNF31', 'SEPTIN2', 'RRAGD', 'CAPN2', 'PLCE1', 'TLN1', 'SEPTIN7', 'PLCD1']",0.9985108186980352,0,0,8
60,Insulin resistance,0.36190527001343326,1.3334351922587218,1.3552672419033371,"['RPS6KA3', 'PYGB', 'IRS1', 'CREB5']",0.9985108186980352,0,0,4
61,Tyrosine metabolism,0.3636668768952532,2.3591397849462368,2.38631000666534,['FAH'],0.9985108186980352,0,0,1
62,Necroptosis,0.3775168651775826,1.302582474996268,1.268897738205148,"['RNF31', 'PYGB', 'FTH1', 'CAPN2']",0.9985108186980352,0,0,4
63,Oocyte meiosis,0.3775168651775826,1.302582474996268,1.268897738205148,"['RPS6KA3', 'PPP3CB', 'CDC27', 'ADCY8']",0.9985108186980352,0,0,4
64,Cortisol synthesis and secretion,0.38671504951986607,1.5306383970177073,1.4542092799065722,"['ADCY8', 'CREB5']",0.9985108186980352,0,0,2
65,Sphingolipid metabolism,0.38671504951986607,1.5306383970177073,1.4542092799065722,"['DEGS2', 'PLPP1']",0.9985108186980352,0,0,2
66,Inositol phosphate metabolism,0.402441712079158,1.3274838012958963,1.2082824030761745,"['INPP5D', 'PLCE1', 'PLCD1']",0.9985108186980352,0,0,3
67,Fat digestion and absorption,0.40643916754000825,2.0218125960061446,1.820280359560625,['PLPP1'],0.9985108186980352,0,0,1
68,"Valine, leucine and isoleucine degradation",0.4228714395912579,1.4155172413793105,1.2183173890650607,"['OXCT1', 'IVD']",0.9985108186980352,0,0,2
69,Steroid biosynthesis,0.42673701977407813,1.8868817204301076,1.6068445743158746,['TM7SF2'],0.9985108186980352,0,0,1
70,Leukocyte transendothelial migration,0.42998997194611,1.2677541020598948,1.0699760843402681,"['VASP', 'RAP1A', 'CTNNA1']",0.9985108186980352,0,0,3
71,PD-L1 expression and PD-1 checkpoint pathway in cancer,0.42998997194611,1.2677541020598948,1.0699760843402681,"['ALK', 'PPP3CB', 'RASGRP1']",0.9985108186980352,0,0,3
72,Tight junction,0.43160268787720113,1.1702013230311397,0.9832614485986902,"['VASP', 'IGSF5', 'RAP1A', 'PPP2R2B', 'AMOTL2']",0.9985108186980352,0,0,5
73,Renin secretion,0.43467953730954983,1.3808873002523128,1.1504810278606528,"['PPP3CB', 'ADORA1']",0.9985108186980352,0,0,2
74,Folate biosynthesis,0.4463421884610553,1.7688172043010753,1.4268506818380347,['CBR1'],0.9985108186980352,0,0,1
75,Type I diabetes mellitus,0.4463421884610553,1.7688172043010753,1.4268506818380347,['HLA-E'],0.9985108186980352,0,0,1
76,Nucleotide excision repair,0.4463562932679493,1.3479064039408868,1.0872722320918806,"['DDB1', 'GTF2H3']",0.9985108186980352,0,0,2
77,RNA degradation,0.44810120656768004,1.2308197952859423,0.9880235617363861,"['BTG1', 'NUDT16', 'PFKP']",0.9985108186980352,0,0,3
78,Protein processing in endoplasmic reticulum,0.4549332157223319,1.1176201372997712,0.8802428164411166,"['FBXO2', 'DNAJB11', 'CAPN2', 'HSPA2', 'CALR', 'SEC62']",0.9985108186980352,0,0,6
79,Morphine addiction,0.45707014080482694,1.2131440913298364,0.9497928538716044,"['GRK3', 'ADORA1', 'ADCY8']",0.9985108186980352,0,0,3
80,Ubiquitin mediated proteolysis,0.4584387348707149,1.132407809110629,0.8831972564365723,"['DDB1', 'FBXO2', 'CDC27', 'KLHL13', 'RHOBTB2']",0.9985108186980352,0,0,5
81,Apelin signaling pathway,0.46214873338707535,1.1554024207085432,0.8918187402683733,"['MRAS', 'NRF1', 'ADCY8', 'KLF2']",0.9985108186980352,0,0,4
82,One carbon pool by folate,0.4652782628810708,1.6646426312460467,1.2736507667117276,['MTR'],0.9985108186980352,0,0,1
83,Melanogenesis,0.4659770632203983,1.1959662945274236,0.9132624263486698,"['FZD3', 'FZD9', 'ADCY8']",0.9985108186980352,0,0,3
84,Progesterone-mediated oocyte maturation,0.4659770632203983,1.1959662945274236,0.9132624263486698,"['RPS6KA3', 'CDC27', 'ADCY8']",0.9985108186980352,0,0,3
85,Retinol metabolism,0.4835680308190383,1.5720430107526882,1.1421887090378822,['ALDH1A1'],0.9985108186980352,0,0,1
86,Fc gamma R-mediated phagocytosis,0.48359319368968223,1.1630225746323857,0.8449489665601037,"['VASP', 'INPP5D', 'PLPP1']",0.9985108186980352,0,0,3
87,Breast cancer,0.4845897268958701,1.1208263683511208,0.8119856551205392,"['NOTCH2', 'NCOA1', 'FZD3', 'FZD9']",0.9985108186980352,0,0,4
88,Hedgehog signaling pathway,0.49166066504722483,1.2303223388305846,0.8734876517035407,"['GRK3', 'GLI1']",0.9985108186980352,0,0,2
89,Thermogenesis,0.49572228611105146,1.0593012011697134,0.7433534063805939,"['RPS6KA3', 'CPT2', 'NDUFAF2', 'UQCR10', 'ADCY8', 'ATP5ME', 'CREB5']",0.9985108186980352,0,0,7
90,Chemical carcinogenesis,0.4979721505528681,1.0800450398238148,0.7530194184605589,"['NOTCH2', 'RPS6KA3', 'CBR1', 'ADCY8', 'CREB5']",0.9985108186980352,0,0,5
91,Systemic lupus erythematosus,0.5012335053792595,1.4891907187323146,1.0285590227544674,['SNRPD1'],0.9985108186980352,0,0,1
92,B cell receptor signaling pathway,0.524068870427104,1.1547325826882477,0.7461098707901248,"['PPP3CB', 'INPP5D']",0.9985108186980352,0,0,2
93,p53 signaling pathway,0.524068870427104,1.1547325826882477,0.7461098707901248,"['SESN1', 'PPM1D']",0.9985108186980352,0,0,2
94,Vascular smooth muscle contraction,0.534677766508345,1.0741996336495612,0.6725467433881256,"['PPP1R12A', 'KCNMB3', 'ADCY8']",0.9985108186980352,0,0,3
95,Pentose phosphate pathway,0.5347759117609447,1.34715821812596,0.8431964005549181,['PFKP'],0.9985108186980352,0,0,1
96,PPAR signaling pathway,0.5448890208348348,1.1092799188640974,0.673524967648995,"['CPT2', 'PLIN2']",0.9985108186980352,0,0,2
97,Galactose metabolism,0.5506932295595334,1.2858260019550343,0.7670947035682092,['PFKP'],0.9985108186980352,0,0,1
98,Metabolism of xenobiotics by cytochrome P450,0.5506932295595334,1.2858260019550343,0.7670947035682092,['CBR1'],0.9985108186980352,0,0,1
99,Amphetamine addiction,0.555058495250825,1.0878647214854111,0.6404061340521106,"['PPP3CB', 'CREB5']",0.9985108186980352,0,0,2
100,Central carbon metabolism in cancer,0.5650660291854646,1.0672576447625244,0.6092042059015388,"['PDGFRB', 'PFKP']",0.9985108186980352,0,0,2
101,Epithelial cell signaling in Helicobacter pylori infection,0.5650660291854646,1.0672576447625244,0.6092042059015388,"['IGSF5', 'ADAM10']",0.9985108186980352,0,0,2
102,Biosynthesis of unsaturated fatty acids,0.5660670742948688,1.2298270219728846,0.6998240915501036,['ELOVL6'],0.9985108186980352,0,0,1
103,Fatty acid elongation,0.5660670742948688,1.2298270219728846,0.6998240915501036,['ELOVL6'],0.9985108186980352,0,0,1
104,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,0.5660670742948688,1.2298270219728846,0.6998240915501036,['PIGM'],0.9985108186980352,0,0,1
105,Inflammatory bowel disease,0.5660670742948688,1.2298270219728846,0.6998240915501036,['RORA'],0.9985108186980352,0,0,1
106,Ovarian steroidogenesis,0.5660670742948688,1.2298270219728846,0.6998240915501036,['ADCY8'],0.9985108186980352,0,0,1
107,Starch and sucrose metabolism,0.5660670742948688,1.2298270219728846,0.6998240915501036,['PYGB'],0.9985108186980352,0,0,1
108,Th1 and Th2 cell differentiation,0.5749107985167451,1.0474137931034482,0.579785832438551,"['NOTCH2', 'PPP3CB']",0.9985108186980352,0,0,2
109,Phosphatidylinositol signaling system,0.5749861441029568,1.009873495834619,0.5588734204581267,"['INPP5D', 'PLCE1', 'PLCD1']",0.9985108186980352,0,0,3
110,Mucin type O-glycan biosynthesis,0.5809159635172502,1.178494623655914,0.6400983810462939,['GALNT8'],0.9985108186980352,0,0,1
111,Pancreatic secretion,0.5845922237497312,1.0282915360501568,0.5520287770399811,"['RAP1A', 'ADCY8']",0.9985108186980352,0,0,2
112,Calcium signaling pathway,0.5912859294500854,0.96796719460375,0.5086237563014463,"['PDGFRB', 'PPP3CB', 'PLCE1', 'ADCY8', 'PLCD1']",0.9985108186980352,0,0,5
113,Human papillomavirus infection,0.5927474524982825,0.9618879494564713,0.5030547504834976,"['PDGFRB', 'NOTCH2', 'FZD3', 'PPP2R2B', 'FZD9', 'COL9A2', 'HLA-E', 'CREB5']",0.9985108186980352,0,0,8
114,Aldosterone-regulated sodium reabsorption,0.5952577850915304,1.131268817204301,0.5868578204797155,['IRS1'],0.9985108186980352,0,0,1
115,Ether lipid metabolism,0.5952577850915304,1.131268817204301,0.5868578204797155,['PLPP1'],0.9985108186980352,0,0,1
116,Phagosome,0.5981002302946332,0.9748268414388918,0.5010580036720126,"['SFTPD', 'CALR', 'HLA-E']",0.9985108186980352,0,0,3
117,Cellular senescence,0.603299747824088,0.9581040428498055,0.4841693619748458,"['PPP3CB', 'MRAS', 'CAPN2', 'HLA-E']",0.9985108186980352,0,0,4
118,Fructose and mannose metabolism,0.6091098186541688,1.0876757650951199,0.5392225494220254,['PFKP'],0.9985108186980352,0,0,1
119,Natural killer cell mediated cytotoxicity,0.6126539854405626,0.9748810939357907,0.47764783065891425,"['PPP3CB', 'HLA-E']",0.9985108186980352,0,0,2
120,Wnt signaling pathway,0.6161427617633999,0.941991341991342,0.45618435132057533,"['TLE2', 'FZD3', 'PPP3CB', 'FZD9']",0.9985108186980352,0,0,4
121,"Growth hormone synthesis, secretion and action",0.6203780709087837,0.9421166306695464,0.4497911582287633,"['IRS1', 'ADCY8', 'CREB5']",0.9985108186980352,0,0,3
122,ABC transporters,0.6224887561273231,1.0473118279569893,0.49645692549237136,['ABCC8'],0.9985108186980352,0,0,1
123,Citrate cycle (TCA cycle),0.6224887561273231,1.0473118279569893,0.49645692549237136,['ACO1'],0.9985108186980352,0,0,1
124,RNA polymerase,0.6224887561273231,1.0473118279569893,0.49645692549237136,['POLR1A'],0.9985108186980352,0,0,1
125,Diabetic cardiomyopathy,0.6258342419527166,0.9293298321726224,0.43554876353060035,"['CPT2', 'IRS1', 'GSR', 'PDK3', 'UQCR10']",0.9985108186980352,0,0,5
126,Human immunodeficiency virus 1 infection,0.6258342419527166,0.9293298321726224,0.43554876353060035,"['DDB1', 'PPP3CB', 'AP1B1', 'CALR', 'HLA-E']",0.9985108186980352,0,0,5
127,Cell cycle,0.6276149561933828,0.9316924975672276,0.4340088511799615,"['STAG1', 'CDC27', 'MCM5']",0.9985108186980352,0,0,3
128,MicroRNAs in cancer,0.6287243690800125,0.9264069264069265,0.4299105505727335,"['PDGFRB', 'NOTCH2', 'FZD3', 'IRS1']",0.9985108186980352,0,0,4
129,Pathways in cancer,0.6404420199591723,0.9277170961317965,0.4133876625014876,"['NOTCH2', 'NCOA1', 'ALK', 'PDGFRB', 'FZD3', 'MSH2', 'TXNRD1', 'CTNNA1', 'FZD9', 'ADCY8', 'GLI1', 'RASGRP1']",0.9985108186980352,0,0,12
130,Autophagy,0.6410400649630126,0.911325233905879,0.4052329042653838,"['MRAS', 'IRS1', 'RRAGD', 'SNAP29']",0.9985108186980352,0,0,4
131,Human cytomegalovirus infection,0.6424362699826816,0.9111328808340914,0.403165054403902,"['PPP3CB', 'CALR', 'ADCY8', 'HLA-E', 'CREB5']",0.9985108186980352,0,0,5
132,Axon guidance,0.6478674419794322,0.9052227598865343,0.3929292906031084,"['ENAH', 'SEMA5B', 'FZD3', 'PPP3CB', 'EPHB2']",0.9985108186980352,0,0,5
133,Th17 cell differentiation,0.6561627023232565,0.8971674876847291,0.37801837991324183,"['PPP3CB', 'RORA']",0.9985108186980352,0,0,2
134,Taste transduction,0.6599455120033683,0.9423655913978495,0.39164525970941116,['ADCY8'],0.9985108186980352,0,0,1
135,Ras signaling pathway,0.6690679186895976,0.8823210412147505,0.35457809328549483,"['PDGFRB', 'MRAS', 'RAP1A', 'PLCE1', 'RASGRP1']",0.9985108186980352,0,0,5
136,SNARE interactions in vesicular transport,0.6715879167267697,0.9118973291710024,0.36303576096952195,['SNAP29'],0.9985108186980352,0,0,1
137,Signaling pathways regulating pluripotency of stem cells,0.6755873901828586,0.864680213338035,0.3391040247812856,"['FZD3', 'ACVR1C', 'FZD9']",0.9985108186980352,0,0,3
138,Sphingolipid signaling pathway,0.6755873901828586,0.864680213338035,0.3391040247812856,"['PPP2R2B', 'ADORA1', 'DEGS2']",0.9985108186980352,0,0,3
139,Hepatocellular carcinoma,0.6820045202695142,0.8621658239978851,0.3299672361314666,"['FZD3', 'TXNRD1', 'FZD9', 'ARID2']",0.9985108186980352,0,0,4
140,Gastric cancer,0.6820552222106862,0.8558806204594541,0.3274981433959319,"['FZD3', 'FZD9', 'CTNNA1']",0.9985108186980352,0,0,3
141,Alzheimer disease,0.6822997357977254,0.8875916206331961,0.3393140476714379,"['BACE1', 'FZD3', 'PPP3CB', 'IRS1', 'FZD9', 'CAPN2', 'ADAM10', 'MAPT', 'UQCR10']",0.9985108186980352,0,0,9
142,Olfactory transduction,0.682832545918536,0.8833333333333333,0.33699663437618615,['GRK3'],0.9985108186980352,0,0,1
143,Pyruvate metabolism,0.682832545918536,0.8833333333333333,0.33699663437618615,['ME2'],0.9985108186980352,0,0,1
144,Viral myocarditis,0.682832545918536,0.8833333333333333,0.33699663437618615,['HLA-E'],0.9985108186980352,0,0,1
145,Bacterial invasion of epithelial cells,0.6880888539485229,0.8433479155944416,0.31527490874412956,"['SEPTIN2', 'CTNNA1']",0.9985108186980352,0,0,2
146,Gap junction,0.6880888539485229,0.8433479155944416,0.31527490874412956,"['PDGFRB', 'ADCY8']",0.9985108186980352,0,0,2
147,Neurotrophin signaling pathway,0.6947023803947286,0.8388041827940893,0.3055526715846477,"['RPS6KA3', 'RAP1A', 'IRS1']",0.9985108186980352,0,0,3
148,Oxidative phosphorylation,0.6947023803947286,0.8388041827940893,0.3055526715846477,"['PPA2', 'UQCR10', 'ATP5ME']",0.9985108186980352,0,0,3
149,Aldosterone synthesis and secretion,0.6956799896697724,0.8308823529411765,0.30149854820033434,"['ADCY8', 'CREB5']",0.9985108186980352,0,0,2
150,C-type lectin receptor signaling pathway,0.6956799896697724,0.8308823529411765,0.30149854820033434,"['PPP3CB', 'MRAS']",0.9985108186980352,0,0,2
151,Chagas disease,0.6956799896697724,0.8308823529411765,0.30149854820033434,"['PPP2R2B', 'CALR']",0.9985108186980352,0,0,2
152,GABAergic synapse,0.6956799896697724,0.8308823529411765,0.30149854820033434,"['ADCY8', 'SLC38A2']",0.9985108186980352,0,0,2
153,Prostate cancer,0.7031178543521679,0.8187781109445277,0.28839883329273525,"['PDGFRB', 'CREB5']",0.9985108186980352,0,0,2
154,Viral carcinogenesis,0.7038956410021151,0.8363636363636363,0.2936683248574575,"['DDB1', 'GTF2H3', 'HLA-E', 'CREB5']",0.9985108186980352,0,0,4
155,Fatty acid degradation,0.7041822649007701,0.8312460468058191,0.29153299869555727,['CPT2'],0.9985108186980352,0,0,1
156,Homologous recombination,0.7041822649007701,0.8312460468058191,0.29153299869555727,['RAD54B'],0.9985108186980352,0,0,1
157,Legionellosis,0.7041822649007701,0.8312460468058191,0.29153299869555727,['HSPA2'],0.9985108186980352,0,0,1
158,T cell receptor signaling pathway,0.7104040363032781,0.8070197044334976,0.27593731167638724,"['PPP3CB', 'RASGRP1']",0.9985108186980352,0,0,2
159,Ferroptosis,0.714313110375249,0.8074347158218126,0.2716483965767846,['FTH1'],0.9985108186980352,0,0,1
160,Vasopressin-regulated water reabsorption,0.714313110375249,0.8074347158218126,0.2716483965767846,['CREB5'],0.9985108186980352,0,0,1
161,Peroxisome,0.71754019432969,0.7955925206410879,0.26407809198359394,"['NUDT7', 'PEX5L']",0.9985108186980352,0,0,2
162,Bile secretion,0.7240977226287086,0.7849462365591398,0.2534033455696793,['ADCY8'],0.9985108186980352,0,0,1
163,Cocaine addiction,0.7240977226287086,0.7849462365591398,0.2534033455696793,['CREB5'],0.9985108186980352,0,0,1
164,Apoptosis,0.7246504085074384,0.7989323118301479,0.25730888247713674,"['DFFA', 'CAPN2', 'SEPTIN4']",0.9985108186980352,0,0,3
165,Dopaminergic synapse,0.7303569287596943,0.7914050988070487,0.24867683029958848,"['PPP3CB', 'PPP2R2B', 'CREB5']",0.9985108186980352,0,0,3
166,Chemokine signaling pathway,0.7359702596852645,0.7840172786177105,0.24035270320838592,"['GRK3', 'RAP1A', 'ADCY8']",0.9985108186980352,0,0,3
167,AGE-RAGE signaling pathway in diabetic complications,0.7380660318899309,0.7631640260950606,0.23178969233566468,"['PLCE1', 'PLCD1']",0.9985108186980352,0,0,2
168,RNA transport,0.7395418542842568,0.7947076397780624,0.23978268606349673,"['CYFIP2', 'NUP210', 'EIF3E', 'AAAS']",0.9985108186980352,0,0,4
169,Arginine and proline metabolism,0.7426750783136448,0.7435200905489531,0.22119472900235,['ODC1'],0.9985108186980352,0,0,1
170,Cytokine-cytokine receptor interaction,0.7446198654723186,0.7529310344827587,0.22202538654814521,"['GDF10', 'ACVR1C']",0.9985108186980352,0,0,2
171,Adrenergic signaling in cardiomyocytes,0.7469197365429688,0.7696446102493618,0.2245804096064389,"['PPP2R2B', 'ADCY8', 'CREB5']",0.9985108186980352,0,0,3
172,Basal transcription factors,0.7514902465580047,0.7244003308519438,0.20695903646073124,['GTF2H3'],0.9985108186980352,0,0,1
173,Other types of O-glycan biosynthesis,0.7514902465580047,0.7244003308519438,0.20695903646073124,['GALNT8'],0.9985108186980352,0,0,1
174,"Parathyroid hormone synthesis, secretion and action",0.7573068057584841,0.7332624272279444,0.2038372874597614,"['ADCY8', 'CREB5']",0.9985108186980352,0,0,2
175,Oxytocin signaling pathway,0.7575039695978302,0.755785251465597,0.20990159356258972,"['PPP3CB', 'PPP1R12A', 'ADCY8']",0.9985108186980352,0,0,3
176,Insulin signaling pathway,0.7677286251495564,0.7424121859724906,0.1962336175914401,"['PYGB', 'IRS1', 'RHOQ']",0.9985108186980352,0,0,3
177,Endocrine and other factor-regulated calcium reabsorption,0.768226792246935,0.6889588250721217,0.18165797115364005,['AP2A1'],0.9985108186980352,0,0,1
178,Fanconi anemia pathway,0.768226792246935,0.6889588250721217,0.18165797115364005,['FANCC'],0.9985108186980352,0,0,1
179,Glycolysis / Gluconeogenesis,0.768226792246935,0.6889588250721217,0.18165797115364005,['PFKP'],0.9985108186980352,0,0,1
180,Mineral absorption,0.768226792246935,0.6889588250721217,0.18165797115364005,['FTH1'],0.9985108186980352,0,0,1
181,Proteasome,0.7761683813460295,0.6725038402457757,0.17040292091837195,['PSME2'],0.9985108186980352,0,0,1
182,RIG-I-like receptor signaling pathway,0.7838384176746467,0.6568142035508877,0.15996866234682394,['DHX58'],0.9985108186980352,0,0,1
183,Cholinergic synapse,0.7866630496682526,0.6882884777123633,0.16515844580074862,"['ADCY8', 'CREB5']",0.9985108186980352,0,0,2
184,Fc epsilon RI signaling pathway,0.7984005808626622,0.6275268817204301,0.14128443087875595,['INPP5D'],0.9985108186980352,0,0,1
185,Drug metabolism,0.8053103040178203,0.613838242169238,0.13291292443970268,['UPP2'],0.9985108186980352,0,0,1
186,VEGF signaling pathway,0.8053103040178203,0.613838242169238,0.13291292443970268,['PPP3CB'],0.9985108186980352,0,0,1
187,Hepatitis B,0.8094633510868401,0.6876152346836644,0.14535070777339007,"['DDB1', 'HSPG2', 'CREB5']",0.9985108186980352,0,0,3
188,Herpes simplex virus 1 infection,0.8144484350016051,0.790506169022793,0.16224677599600132,"['ZNF441', 'ZNF891', 'ZNF583', 'ZNF81', 'ZNF44', 'CALR', 'ZNF763', 'ZNF433', 'ZNF564', 'HLA-E', 'ZNF442']",0.9985108186980352,0,0,11
189,Melanoma,0.8246534324045837,0.5761246434057494,0.11107225845540034,['PDGFRB'],0.9985108186980352,0,0,1
190,GnRH secretion,0.8306651112004743,0.5645591397849462,0.10474184440639167,['GPER1'],0.9985108186980352,0,0,1
191,Salivary secretion,0.842078442200152,0.5427626137303556,0.09329118182313444,['ADCY8'],0.9985108186980352,0,0,1
192,Relaxin signaling pathway,0.8446925458144329,0.5998716067498165,0.10124787082261012,"['ADCY8', 'CREB5']",0.9985108186980352,0,0,2
193,Arrhythmogenic right ventricular cardiomyopathy,0.8474939004371235,0.5324812335159261,0.08811054131657399,['CTNNA1'],0.9985108186980352,0,0,1
194,Endometrial cancer,0.8474939004371235,0.5324812335159261,0.08811054131657399,['CTNNA1'],0.9985108186980352,0,0,1
195,Adipocytokine signaling pathway,0.8527240336845976,0.5225806451612903,0.08325718688584727,['IRS1'],0.9985108186980352,0,0,1
196,Lipid and atherosclerosis,0.8617189756097847,0.6166858476139427,0.09177893473044503,"['PPP3CB', 'RAP1A', 'HSPA2']",0.9985108186980352,0,0,3
197,Cardiac muscle contraction,0.8719147038964775,0.4863922877271042,0.06666671517225692,['UQCR10'],0.9985108186980352,0,0,1
198,Endocytosis,0.8778704997499984,0.6507592190889371,0.08476541701652676,"['GRK3', 'AP2A1', 'HSPA2', 'VPS45', 'HLA-E']",0.9985108186980352,0,0,5
199,FoxO signaling pathway,0.8816858373351054,0.5417771883289124,0.06822030178956774,"['IRS1', 'KLF2']",0.9985108186980352,0,0,2
200,Huntington disease,0.8856746104558754,0.660920716112532,0.08023951089230329,"['DNAH12', 'KCNJ10', 'AP2A1', 'UQCR10', 'NRF1', 'CREB5']",0.9985108186980352,0,0,6
201,PI3K-Akt signaling pathway,0.887156642061264,0.6387300335239597,0.07647751958848853,"['PDGFRB', 'IRS1', 'PPP2R2B', 'COL9A2', 'CREB5']",0.9985108186980352,0,0,5
202,Hepatitis C,0.8880327387064619,0.531473649967469,0.06311072546570204,"['PPP2R2B', 'EIF3E']",0.9985108186980352,0,0,2
203,Mitophagy,0.8886093738514859,0.45487339576829694,0.05371942883544415,['MRAS'],0.9985108186980352,0,0,1
204,Dilated cardiomyopathy,0.8924319805756341,0.44761904761904764,0.05094127697355209,['ADCY8'],0.9985108186980352,0,0,1
205,TGF-beta signaling pathway,0.8924319805756341,0.44761904761904764,0.05094127697355209,['ACVR1C'],0.9985108186980352,0,0,1
206,Glioma,0.8961236756388739,0.4405913978494624,0.0483226743117601,['PDGFRB'],0.9985108186980352,0,0,1
207,Inflammatory mediator regulation of TRP channels,0.8961236756388739,0.4405913978494624,0.0483226743117601,['ADCY8'],0.9985108186980352,0,0,1
208,Renal cell carcinoma,0.8961236756388739,0.4405913978494624,0.0483226743117601,['RAP1A'],0.9985108186980352,0,0,1
209,Non-small cell lung cancer,0.8996889330229478,0.4337799834574028,0.04585323601940463,['ALK'],0.9985108186980352,0,0,1
210,Pancreatic cancer,0.9064572727076703,0.42076713208152783,0.041324122489707786,['ARHGEF6'],0.9985108186980352,0,0,1
211,Ribosome biogenesis in eukaryotes,0.9096685606608601,0.41454775458570525,0.039247294101970275,['NAT10'],0.9985108186980352,0,0,1
212,Retrograde endocannabinoid signaling,0.9103903841815887,0.4938747731397459,0.04636584174085904,"['RIMS1', 'ADCY8']",0.9985108186980352,0,0,2
213,GnRH signaling pathway,0.9186572416278512,0.3969407844918976,0.03367732745939145,['ADCY8'],0.9985108186980352,0,0,1
214,Colorectal cancer,0.9292689997541678,0.3756559139784946,0.02755699977786488,['MSH2'],0.9985108186980352,0,0,1
215,Toxoplasmosis,0.9292689997541678,0.3756559139784946,0.02755699977786488,['HSPA2'],0.9985108186980352,0,0,1
216,Prion disease,0.9316894630234315,0.5451183121086034,0.03857023538713459,"['PPP3CB', 'UQCR10', 'HSPA2', 'CREB5']",0.9985108186980352,0,0,4
217,JAK-STAT signaling pathway,0.9316985816546481,0.3706847764572722,0.02622443807843534,['PDGFRB'],0.9985108186980352,0,0,1
218,Circadian entrainment,0.9340448784661946,0.36584275939114647,0.0249617412785169,['ADCY8'],0.9985108186980352,0,0,1
219,Spinocerebellar ataxia,0.9343748097403164,0.4500344827586207,0.03054727231927366,"['RORA', 'PUM2']",0.9985108186980352,0,0,2
220,Spliceosome,0.9362247223305562,0.44642857142857145,0.02941952828618352,"['SNRPD1', 'HSPA2']",0.9985108186980352,0,0,2
221,Osteoclast differentiation,0.9363107393308353,0.36112489660876756,0.023764860659774737,['PPP3CB'],0.9985108186980352,0,0,1
222,TNF signaling pathway,0.9363107393308353,0.36112489660876756,0.023764860659774737,['CREB5'],0.9985108186980352,0,0,1
223,Neuroactive ligand-receptor interaction,0.938025184509242,0.4428794461037198,0.028334754307276708,"['GPR35', 'ADORA1']",0.9985108186980352,0,0,2
224,mRNA surveillance pathway,0.9426527570274106,0.34767025089605735,0.020532465046645614,['PPP2R2B'],0.9985108186980352,0,0,1
225,Non-alcoholic fatty liver disease,0.9431418476260904,0.4325596816976127,0.025321432127244477,"['IRS1', 'UQCR10']",0.9985108186980352,0,0,2
226,Alcoholism,0.9465265940006817,0.33924083430496177,0.018643391048505726,['CREB5'],0.9985108186980352,0,0,1
227,Kaposi sarcoma-associated herpesvirus infection,0.9493423873904266,0.4195187853834277,0.021809002004992046,"['PPP3CB', 'HLA-E']",0.9985108186980352,0,0,2
228,HIF-1 signaling pathway,0.95013926349243,0.3312080961416825,0.016940205099249917,['PFKP'],0.9985108186980352,0,0,1
229,Measles,0.9566502086770341,0.3162256856348919,0.014014319970367378,['HSPA2'],0.9985108186980352,0,0,1
230,Epstein-Barr virus infection,0.9610216700024082,0.39284422474077646,0.015618826725771709,"['CALR', 'HLA-E']",0.9985108186980352,0,0,2
231,Fluid shear stress and atherosclerosis,0.9683636847859299,0.2869870528856704,0.009225932021712293,['KLF2'],0.9985108186980352,0,0,1
232,Tuberculosis,0.9715183144038305,0.27839880762269775,0.008044377718604799,['PPP3CB'],0.9985108186980352,0,0,1
233,NOD-like receptor signaling pathway,0.9769168127411061,0.26266706863631795,0.006134267928772613,['RNF31'],0.9985108186980352,0,0,1
234,Transcriptional misregulation in cancer,0.9769168127411061,0.26266706863631795,0.006134267928772613,['ETV1'],0.9985108186980352,0,0,1
235,Yersinia infection,0.9784789337324222,0.25780802998914865,0.0056088770489726315,['RPS6KA3'],0.9985108186980352,0,0,1
236,Pathways of neurodegeneration,0.9814165692320992,0.5094000466447095,0.009555464737783124,"['DNAH12', 'FZD3', 'PPP3CB', 'CAPN2', 'FZD9', 'MAPT', 'UQCR10']",0.9985108186980352,0,0,7
237,Ribosome,0.988945275818063,0.21922043010752687,0.0024369160628264805,['MRPS6'],0.9985108186980352,0,0,1
238,Amyotrophic lateral sclerosis,0.9937003538880858,0.3690834551761704,0.0023324496953044615,"['DNAH12', 'PPP3CB', 'NUP210', 'UQCR10']",0.9985108186980352,0,0,4
239,Pathogenic Escherichia coli infection,0.9939133701771977,0.1932665925101965,0.001179936778812389,['CYFIP2'],0.9985108186980352,0,0,1
240,Parkinson disease,0.994367620280201,0.2700524737631184,0.001525337761084066,"['MAPT', 'UQCR10']",0.9985108186980352,0,0,2
241,Salmonella infection,0.9992079641243916,0.13743312675459504,0.00010889509699335827,['CYFIP2'],0.9992079641243916,0,0,1
